ArticleResearch and practice in thrombosis and haemostasis2023

Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients.

Ingrid Pabinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.